| Financial Year |
March 31 2023 |
| Monetary Funds |
185,210,255.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
339,014,892.30 |
| Accounts Receivable |
618,632,300.90 |
| Advances to Suppliers |
24,188,040.76 |
| Other Receivables |
5,573,790.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
199,972,932.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,506,311.07 |
| Total Current Assets |
1,473,684,357.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,976,870.32 |
| Fixed Assetes |
346,624,748.08 |
| Under-construction Projects |
225,838,204.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,108,108.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
39,610,299.36 |
| Deferred Income Tax Assets |
8,715,778.90 |
| Other Non-Current Assets |
115,415,822.34 |
| Sub-Total of Non-Current Assets |
869,389,751.27 |
| Total Assets |
2,343,074,109.07 |
| Short-Term Loans |
795,879,229.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
95,766,570.00 |
| Accounts Payable |
216,566,807.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,133,625.20 |
| Taxes Payable |
9,251,535.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,818,422.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,035,048.48 |
| Other Current Liabilities |
209,282,394.45 |
| Sub-Total of Current Liabilities |
1,421,358,006.83 |
| Long-term Loans |
79,803,031.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,815,760.49 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
516,559.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,439,775.13 |
| Total Liabilities |
1,523,797,781.96 |
| Paid-In Capital(Or Share Stock) |
100,379,360.00 |
| Capital Surplus |
378,512,307.61 |
| Surplus Reserve |
3,935,895.64 |
| LESS:Treasury Stock |
14,872,464.00 |
| Undistributed Profits |
345,318,786.49 |
| Minority Stockholder's Interest |
3,941,333.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
815,334,993.33 |
| Owner's Equity（Stockholder's Equity） |
819,276,327.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,343,074,109.07 |
